Roth Capital Assumes bluebird bio (BLUE) at Buy

September 22, 2016 8:15 AM EDT
Get Alerts BLUE Hot Sheet
Price: $66.41 -3.91%

Rating Summary:
    16 Buy, 3 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 15 | Down: 23 | New: 57
Trade BLUE Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Roth Capital assumed coverage on bluebird bio (NASDAQ: BLUE) with a Buy rating and a price target of $87.00.

For an analyst ratings summary and ratings history on bluebird bio click here. For more ratings news on bluebird bio click here.

Shares of bluebird bio closed at $73.81 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment